GSK is inviting academic scientists to enter their most innovative drug research proposals into its 2014 Discovery Fast Track Challenge– a program designed to accelerate the translation of early-stage research into game-changing new medicines.
Building on the success of its first program in 2013, which ran in the United States and Canada, GSK is implementing the challenge for a second year and expanding it to include Europe. Scientists who participate in the challenge are asked to submit details about the biological targets or pathways they are researching and the scientific rationale detailing how this early stage research could direct future drug development.